Back to Sectors
LNZA
technologyLanzaTech Global, Inc.
biotechnologySmall Cap ($300M-2B)1 filings tracked
Signal Timeline
neutralApr 17
LanzaTech replaced Deloitte with BDO as its independent auditor.
management change
70%
bearishApr 17
Previous audit reports flagged substantial doubt regarding the company's ability to continue as a going concern.
dilution risk
60%